Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.
Thermo Fisher Scientific will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.
Further strengthens Thermo Fisher’s position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attractive return profile...
Mettler-Toledo has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
President Donald Trump used a swing through Ohio and Kentucky to push an economic message and attack fellow Republican Rep. Thomas Massie — even as the conflict in Iran threatened to overshadow all else...
Although Agilent Technologies has underperformed the S&P 500 recently, analysts remain highly optimistic about the stock’s prospects.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on April...
Although Thermo Fisher Scientific stock has declined over the past year, it has slightly outperformed other medical device stocks, and analysts remain highly bullish about its prospects.
3 S&P 500 Stocks We’re Skeptical Of